First human test for new heart failure drug shows safety
NCT ID NCT04045405
Summary
This was a small, early-stage study to check if a new drug called CDR132L is safe for people with stable heart failure caused by heart disease. It involved 28 patients and compared the drug to a placebo. The main goal was to see how the body processes the drug and to identify any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Richmond Pharmacology Ltd., 1A Newcomen Street, London Bridge
London, SE1 1YR, United Kingdom
Conditions
Explore the condition pages connected to this study.